| CTRI Number |
CTRI/2024/07/070086 [Registered on: 05/07/2024] Trial Registered Prospectively |
| Last Modified On: |
04/07/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Conversion of haridradi oil to cream to study their effect in patients with melasma |
|
Scientific Title of Study
|
A comparitive pharmaceutico analytical and clinical evaluation of Haridradi taila and conversion to cream in the management of vyanga w.s.r to melasma |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| Nil |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Swathi K S |
| Designation |
PG Scholar |
| Affiliation |
ALN Rao Memorial Ayurvedic Medical College |
| Address |
Department of Rasashastra and Bhaishajya kalpana ALN Rao Memorial Ayurvedic Medical College Koppa, Chikmagalur Karnataka
Chikmagalur KARNATAKA 577126 India |
| Phone |
8951300131 |
| Fax |
|
| Email |
swathi23ks@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Jagadeesha mayya A |
| Designation |
Professor |
| Affiliation |
ALN Rao Memorial Ayurvedic Medical College |
| Address |
Department of Rasashastra and Bhaishajya kalpana ALN Rao Memorial Ayurvedic Medical College Koppa, Chikmagalur Karnataka
Chikmagalur KARNATAKA 577126 India |
| Phone |
9448525235 |
| Fax |
|
| Email |
jagdeeshmayya@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Swathi K S |
| Designation |
PG Scholar |
| Affiliation |
ALN Rao Memorial Ayurvedic Medical College |
| Address |
Department of Rasashastra and Bhaishajya kalpana ALN Rao Memorial Ayurvedic Medical College Koppa, Chikmagalur Karnataka
Chikmagalur KARNATAKA 577126 India |
| Phone |
8951300131 |
| Fax |
|
| Email |
swathi23ks@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Rasashastra and Bhaishajya kalpana, ALN Rao Memorial Ayurvedic Medical College, Koppa, Chikkmagalur, Karnataka-577126 |
|
|
Primary Sponsor
|
| Name |
Dr Swathi K S |
| Address |
Department of Rasashastra and Bhaishajya kalpana, ALN Rao Memorial Ayurvedic Medical College, Koppa, Chikkmagalur, Karnataka-577126 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Swathi K S |
Aroor Laxminarayana Rao Memorial Ayurvedic Medical College Hospital |
Department of Rasashastra and Bhaishajya kalpana, General OPD division, Room number 16 Chikmagalur KARNATAKA |
8951300131
swathi23ks@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| ALN Rao Memorial Ayurvedic Medical College |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:L819||Disorder of pigmentation, unspecified. Ayurveda Condition: VYANGAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Other than Classical | | (1) Medicine Name: Haridradi Cream, Reference: NA, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: cream of quantity suffecient applied over face only | | 2 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Haridradi Taila, Reference: Chakradatta , Route: Topical, Dosage Form: Taila, Dose: 8(drops), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: |
|
|
|
Inclusion Criteria
|
| Age From |
16.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1. Patients with clinical signs of Vyanga as per Ayurvedic classics will be included.
2. Patients between age group of 16 to 60 years will be selected for the study.
3. Patients irrespective of sex, religion and occupation will be selected for the study. |
|
| ExclusionCriteria |
| Details |
1. Female on oral contraceptive pills, pregnant women, lactating women.
2. Hyperpigmentation since birth.
3. Any other condition interfering the course of treatment. |
|
|
Method of Generating Random Sequence
|
Permuted block randomization, fixed |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. Number of circular lesions
2. Color of skin lesion
3. Area of distribution of skin lesion |
21 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Not applicable |
Not applicable |
|
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
15/07/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="0" Days="21" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This is a comparitive pharmaceutico analytical and clinical evaluation of Haridradi taila and conversion to cream for 21 days. This study comprise of two groups of 20 subjects with Vyanga. Study will be conducted in ALN Rao Memorial Ayurvedic Hospital in Koppa taluk, Chikmagalur district, Karnataka 577126, Primary outcome measure will be Number of circular lesions present over the face, Dark brown color lesion over the skin and Area of distribution of painless lesion. |